With respects to pricing and reimbursement, the societies reportedly call for the criteria that led ...
Read moreDurvalumab was previously made available to NHS patients in 2019 through the Cancer Drugs Fund (CDF)...
Read moreThe research looks at the benefits for 13 medicines across four treatment areas.
Read moreThe EHDS will integrate three main product markets for primary use of health data: electronic health...
Read moreThe data is derived from the Organisation for Economic Co-operation and Development (OECD) Health St...
Read moreSpending by the main health insurance fund (Caisse nationale d’assurance maladie, CNAM) on medicin...
Read moreEUCOPE notes that “while these proposals don’t necessarily represent the final options included ...
Read moreAccording to the ABPI, over the last 20 years, 82% of technology appraisal recommendations have been...
Read moreLegislation published in the Journal Officiel on 14th April 2022 establishes a first list of similar...
Read moreThe paper examines potential reforms to current policies and practices related to orphan drug develo...
Read more